Joel Greenblatt's TMO Position Overview
Joel Greenblatt (via Gotham Asset Management, LLC) currently holds 72,758 shares of Thermo Fisher Scientific Inc. (TMO) worth $42.16 M, representing 0.15% of the portfolio. First purchased in 2014-Q3, this long-term strategic position has been held for 38 quarters.
Based on 13F filings, Joel Greenblatt has maintained a strategic position in TMO, demonstrating sustained confidence in this investment. Largest addition occurred in Q2 2025, adding 41,418 shares. Largest reduction occurred in Q2 2019, reducing 23,940 shares.
Analysis based on 13F filings available since 2013 Q2
Joel Greenblatt's Thermo Fisher Scientific (TMO) Holding Value Over Time
Track share changes against reported price movement
Quarterly Thermo Fisher Scientific (TMO) Trades by Joel Greenblatt
| Report Date | Bought/Sold (Sh.) | % Change | Qtr. End Shares | Reported Price |
|---|---|---|---|---|
| Q4 2025 | +982 | Add 1.37% | 72,758 | $579.45 |
| Q3 2025 | -7,986 | Reduce 10.01% | 71,776 | $485.02 |
| Q2 2025 | +41,418 | Add 108.02% | 79,762 | $405.46 |
| Q1 2025 | +8,993 | Add 30.64% | 38,344 | $497.60 |
| Q4 2024 | +5,944 | Add 25.39% | 29,351 | $520.23 |
| Q3 2024 | +2,125 | Add 9.98% | 23,407 | $618.57 |
| Q2 2024 | +7,164 | Add 50.74% | 21,282 | $553.00 |
| Q1 2024 | +9,218 | Add 188.12% | 14,118 | $581.21 |
| Q4 2023 | +2,246 | Add 84.63% | 4,900 | $530.79 |
| Q3 2023 | +855 | Add 47.53% | 2,654 | $506.17 |
| Q2 2023 | -702 | Reduce 28.07% | 1,799 | $521.75 |
| Q1 2023 | -1,798 | Reduce 41.82% | 2,501 | $576.37 |
| Q4 2022 | +2,330 | Add 118.33% | 4,299 | $550.69 |
| Q3 2022 | +75 | Add 3.96% | 1,969 | $507.36 |
| Q2 2022 | -5,089 | Reduce 72.88% | 1,894 | $543.29 |
| Q1 2022 | -2,561 | Reduce 26.83% | 6,983 | $590.72 |
| Q4 2021 | +6,863 | Add 255.99% | 9,544 | $667.23 |
| Q3 2021 | -9,953 | Reduce 78.78% | 2,681 | $571.43 |
| Q2 2021 | -15,202 | Reduce 54.61% | 12,634 | $504.43 |
| Q1 2021 | -2,136 | Reduce 7.13% | 27,836 | $456.39 |
| Q4 2020 | +17,365 | Add 137.74% | 29,972 | $465.77 |
| Q3 2020 | +11,093 | Add 732.69% | 12,607 | $441.50 |
| Q2 2020 | -1,009 | Reduce 39.99% | 1,514 | $362.62 |
| Q1 2020 | +1,075 | Add 74.24% | 2,523 | $283.79 |
| Q4 2019 | -1,715 | Reduce 54.22% | 1,448 | $324.59 |
| Q3 2019 | -13,498 | Reduce 81.02% | 3,163 | $291.18 |
| Q2 2019 | -23,940 | Reduce 58.96% | 16,661 | $293.68 |
| Q1 2019 | +1,181 | Add 3.00% | 40,601 | $273.71 |
| Q4 2018 | +25,830 | Add 190.07% | 39,420 | $223.80 |
| Q3 2018 | +13,590 | New Buy | 13,590 | $244.08 |
| Q3 2017 | -2,478 | Sold Out | 0 | $0.00 |
| Q2 2017 | -8,413 | Reduce 77.25% | 2,478 | $174.33 |
| Q1 2017 | +10,891 | New Buy | 10,891 | $153.61 |
| Q3 2016 | -1,790 | Sold Out | 0 | $0.00 |
| Q2 2016 | -2,897 | Reduce 61.81% | 1,790 | $147.49 |
| Q1 2016 | +4,687 | New Buy | 4,687 | $141.67 |
| Q4 2014 | -3,314 | Sold Out | 0 | $0.00 |
| Q3 2014 | +3,314 | New Buy | 3,314 | $121.61 |
Joel Greenblatt's Thermo Fisher Scientific Investment FAQs
Joel Greenblatt first purchased Thermo Fisher Scientific Inc. (TMO) in Q3 2014, acquiring 3,314 shares, as reported in their 13F filing for that period. Note: Analysis reflects filings available since Q2 2013; earlier records may be incomplete.
Joel Greenblatt has held Thermo Fisher Scientific Inc. (TMO) for 38 quarters since Q3 2014.
Joel Greenblatt's largest addition to Thermo Fisher Scientific Inc. (TMO) was in Q2 2025, adding 79,762 shares worth $32.34 M.
According to the latest 13F filing for Q4 2025, Joel Greenblatt's firm, Gotham Asset Management, LLC, owns 72,758 shares of Thermo Fisher Scientific Inc. (TMO), valued at approximately $42.16 M.
As of the Q4 2025 filing, Thermo Fisher Scientific Inc. (TMO) represents approximately 0.15% of Joel Greenblatt's publicly disclosed stock portfolio, making it one of their key holdings.
Joel Greenblatt's peak holding in Thermo Fisher Scientific Inc. (TMO) was 79,762 shares, as reported at the end of Q2 2025.